Original paper
Time to CA19.9 nadir: a clue for defining treatment duration of primary chemotherapy in resectable PDAC
Abstract
Introduction: We analyzed time to CA19-9 nadir during first-line chemotherapy in patients with metastatic, unresectable, and borderline resectable pancreatic ductal adenocarcinoma (PDAC) to investigate the relationship between biomarker response and duration of chemotherapy Methods: We analyzed data of PDAC patients with elevated CA19-9 baseline levels who received ≥4 months chemotherapy from the databases of prospective trials conducted at our...
Paper Details
Title
Time to CA19.9 nadir: a clue for defining treatment duration of primary chemotherapy in resectable PDAC
Published Date
Jul 1, 2019
Journal
Volume
30
Pages
iv111 - iv111
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History